采用抗胸腺细胞球蛋白(atg)或抗淋巴细胞球蛋白(ALG)免疫疗法是不适宜于骨髓移植患儿的主要治疗方法。
Immunotherapy with either antithymocyte globulin (ATG) or antilymphocyte globulin (ALG) is the primary treatment for those children not candidates for bone marrow transplant.
目的探讨低剂量、短疗程的抗胸腺细胞球蛋白（ATG）治疗肾移植后早期激素耐受性排斥反应的疗效。
AIM To explore the effect of low-dose and short-term antithymocyte globulin(ATG) in treatment of early steroid-resistant rejection after renal transplantation.
同胞捐赠者的造血干细胞移植之前的预处理方案中使用抗胸腺细胞球蛋白一直是有争议的。
The use of antithymocyte globulin in a conditioning regimen prior to hematopoietic stem cell transplantation with a sibling donor has been controversial.
预处理方案中加入抗胸腺细胞球蛋白从而可以减少移植失败缺少显著提高存活率的证据。
The addition of antithymocyte globulin to any conditioning regimen in order to decrease graft failure is lacking evidence of significantly increased survival.
明确地说，该研究团队发现，在对心脏移植努力产生免疫耐受的老迈小鼠中，对其进行去势手术可导致其机体长期地接受移植物并恢复胸腺细胞的产生。
Specifically, in elderly mice struggling to develop tolerance to cardiac transplants, surgical castration led to long-term graft acceptance and restoration of thymus cells, the team found.
在预处理方案中的抗胸腺细胞球蛋白似乎只在男性造血干细胞移植到的女性接受者中成立。
The use of antithymocyte globulin might be beneficial in order to overcome the in vitro reactivity of lymphocytes against H-Y-encoded gene products in females who eventually may reject male grafts.
在预处理方案中的抗胸腺细胞球蛋白似乎只在男性造血干细胞移植到的女性接受者中成立。
The use of antithymocyte globulin might be beneficial in order to overcome the in vitro reactivity of lymphocytes against H-Y-encoded gene products in females who eventually may reject male grafts.
应用推荐